Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

HAT-SIL-TG-1&AT

SKU: orb1982607

Description

HAT-SIL-TG-1&AT is a hypoxia-activated prodrug that acts as a Janus kinase (JAK) inhibitor. It exerts antitumor effects by blocking the JAK-STAT pathway, suppressing HEL cell proliferation and reducing phospho-STAT3/5 levels under hypoxia, making it a tool for studying hypoxia-targeted oncology research.

Research Area

Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

Key Properties

MW1236.36
FormulaC60H69N17O11S
TargetOthers,JAK,STAT

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information